Use cases
GBM PDO—not U87 spheroids and not a full PSC cerebral-organoid induction course.
| Use | Fit | Readout | Notes |
|---|---|---|---|
| GBM resection PDO biobank + drug / immunotherapy pilots | Recommended | Heterogeneity retention, drugs, and CAR-T contrasts[1][2] | Jacob / STAR Protocols support banking and mouse orthotopic follow-up. |
| Co-culture / invasion contrasts with PSC brain organoids | Contrast | Invasion distance, lineage markers | PSC brain organoids are a separate page—do not import induction steps into GBM banking. |
| U87 / LN229 spheroids as GBM PDO | Do not mix | Spheroid diameter | Cell-line spheroids are not PDOs. |
In one line
GBM mince → dome/suspension → EGF/FGF2 neural-tumor niche → brief Y-27632 → passage → SOX2/Nestin → drugs.
Protocol overview
- Ethics + cold chain; log IDH / MGMT status and resection site
- Trim necrosis; mince ± gentle digest to clusters (not a pure single-cell grind)
- Matrix embed or literature suspension; Neurobasal / B-27 / N-2 + EGF / FGF2[[1]][[2]]
- Brief Y-27632; score solid / invasive-like growth
- Feed every 2–3 days; mechanical split; log passage and medium lots
- SOX2, Nestin, ±MAP2; mycoplasma; match the primary
- Drug / CAR-T arms with vehicle; orthotopic grafts use transplant SOPs—not this page